7-143477937-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176883.2(TAS2R41):c.65C>T(p.Ala22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176883.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R41 | NM_176883.2 | c.65C>T | p.Ala22Val | missense_variant | 1/1 | ENST00000408916.1 | NP_795364.2 | |
EPHA1-AS1 | NR_033897.1 | n.207-26837C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R41 | ENST00000408916.1 | c.65C>T | p.Ala22Val | missense_variant | 1/1 | 6 | NM_176883.2 | ENSP00000386201.1 | ||
EPHA1-AS1 | ENST00000429289.5 | n.207-26837C>T | intron_variant | 1 | ||||||
EPHA1-AS1 | ENST00000690912.1 | n.228-18029C>T | intron_variant | |||||||
EPHA1-AS1 | ENST00000703017.1 | n.206-18029C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152128Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249414Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135320
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727246
GnomAD4 genome AF: 0.000197 AC: 30AN: 152246Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 13AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | The c.65C>T (p.A22V) alteration is located in exon 1 (coding exon 1) of the TAS2R41 gene. This alteration results from a C to T substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at